154 related articles for article (PubMed ID: 33880681)
1. Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.
Xu Y; Tang L; Chen P; Chen M; Zheng M; Shi F; Wang Y
AAPS PharmSciTech; 2021 Apr; 22(4):137. PubMed ID: 33880681
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
3. Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity.
Gao L; Zhang L; He F; Chen J; Zhao M; Li S; Wu H; Liu Y; Zhang Y; Ping Q; Hu L; Qiao H
Int J Nanomedicine; 2021; 16():3581-3598. PubMed ID: 34079251
[TBL] [Abstract][Full Text] [Related]
4. Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer.
Hu Q; Liang B; Sun Y; Guo XL; Bao YJ; Xie DH; Zhou M; Duan YR; Yin PH; Peng ZH
Int J Nanomedicine; 2014; 9():4035-41. PubMed ID: 25187707
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
6. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
[TBL] [Abstract][Full Text] [Related]
7. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
8. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
9. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
12. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
[TBL] [Abstract][Full Text] [Related]
13. Influencing Selectivity to Cancer Cells with Mixed Nanoparticles Prepared from Albumin-Polymer Conjugates and Block Copolymers.
Jiang Y; Wong S; Chen F; Chang T; Lu H; Stenzel MH
Bioconjug Chem; 2017 Apr; 28(4):979-985. PubMed ID: 28263565
[TBL] [Abstract][Full Text] [Related]
14. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
[TBL] [Abstract][Full Text] [Related]
15. Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.
Zhang H; Huang N; Yang G; Lin Q; Su Y
Oncotarget; 2017 Sep; 8(38):63311-63323. PubMed ID: 28968991
[TBL] [Abstract][Full Text] [Related]
16. Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity.
Chen Q; Liu J
Int J Nanomedicine; 2018; 13():6009-6018. PubMed ID: 30323588
[TBL] [Abstract][Full Text] [Related]
17. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
19. Design of dual targeting immunomicelles loaded with bufalin and study of their anti-tumor effect on liver cancer.
Gou H; Huang RC; Zhang FL; Su YH
J Integr Med; 2021 Sep; 19(5):408-417. PubMed ID: 34130942
[TBL] [Abstract][Full Text] [Related]
20. Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.
Zhang JY; He B; Qu W; Cui Z; Wang YB; Zhang H; Wang JC; Zhang Q
J Microencapsul; 2011; 28(6):528-36. PubMed ID: 21702701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
